Cargando…
Global perspectives on CYP2D6 associations with primaquine metabolism and Plasmodium vivax radical cure
Clinical trial and individual patient treatment outcomes have produced accumulating evidence that effective primaquine (PQ) treatment of Plasmodium vivax and P. ovale liver stage hypnozoites is associated with genetic variation in the human cytochrome P450 gene, CYP2D6. Successful PQ treatment of in...
Autores principales: | Olvany, Jasmine M., Williams, Scott M., Zimmerman, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705595/ https://www.ncbi.nlm.nih.gov/pubmed/36457706 http://dx.doi.org/10.3389/fphar.2022.752314 |
Ejemplares similares
-
Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax
por: Stewart, Alexandra G. A., et al.
Publicado: (2021) -
Primaquine radical cure of Plasmodium vivax: a critical review of the literature
por: John, George K, et al.
Publicado: (2012) -
Active Pharmacovigilance for Primaquine Radical Cure of Plasmodium vivax Malaria in Odisha, India
por: Anvikar, Anupkumar R., et al.
Publicado: (2022) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
por: Taylor, Walter R. J., et al.
Publicado: (2023) -
Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters
por: Popovici, Jean, et al.
Publicado: (2021)